This website is intended for an international audience, excluding the UK, United States, Canada and France
This website is intended for an international audience, excluding the UK, United States, Canada and France

Octreotide scan

An octreotide scan – also known as somatostatin receptor scintigraphy (SRS) – may be used to detect certain neuroendocrine cancer cells in the body. The test requires multiple scans, usually taken over 2 days.

On the first day, you will receive an injection that contains a very small amount of a radioactive substance called an octreotide tracer.

Octreotide is a drug very similar to somatostatin.

Neuroendocrine cells with somatostatin receptors on their surface (which are usually of low grade) will attract and attach to the octreotide tracer.

Later that day, the first set of scans will be taken to look for areas in the body that have picked up this tracer, which may indicate where certain neuroendocrine cancer cells are located. Further octreotide scans may need to be taken over the next 24 to 48 hours to produce more detailed pictures.

Positron emission tomography (PET)

A PET scan is a unique type of imaging test that allows doctors to view the activity of cells making up the organs and tissues inside the body. This scan involves injecting a very small dose of a radioactive chemical, called a tracer, into the vein of your arm.

PET scans can detect and record the energy given off by the tracer in your cells.

Detailed, three-dimensional images from the PET scan are then produced through a computer. A PET scan is usually used in combination with a CT scan or MRI scan to build up a picture of the size, location and status of NETs.

Certain types of radioactive tracers can be used in PET scans to detect particular types of NETs:

Bone scintigraphy scan

A bone scintigraphy scan is an imaging test that uses a very small amount of a radioactive substance to determine if NET cancer has spread to the bones from another part of the body.

Usually the entire body is scanned during a bone scan procedure.

If the results show bone damage that may be caused by cancer, then more diagnostic NET tests may be necessary. These may include a CT scan, an MRI scan, or taking a biopsy.

MIBG scintigraphy scan

A MIBG scan is another imaging test that can be carried out to find the location of NETs in the body, but it is used less often than an octreotide scan.

It works by injecting a substance called an isotope into your veins. The MIBG scan is named after the chemical ‘iodine-131-metaiodobenzylguanidine’ or MIBG for short, to which the isotope is attached.

After it is injected, the isotope travels around the body and sticks to any abnormal areas in the body. Several hours or days later the body is scanned with a gamma camera to look for areas that have picked up the isotope.

This allows doctors to identify and pinpoint any areas of abnormality, mainly used for certain types of NETs (such as paragangliomas and phaechromocytomas).


About NETs

Follow this topic

Rate this content

Rating: 4.0/5. From 1 vote.
Please wait...

Find out more about NETs

Learn about NETs

Learn about NETs

Learn about the different types of NETs, symptoms of NETs, their diagnosis and treatment.

Learn About NETs
Treating NETs

Treating NETs

Read about treatment options for NETs, including surgery, radiotherapy and medications.

Treatment Options
FAQs by experts


Have a question about NETs? See if it has been answered by one of our experts

View FAQs

Ipsen logo
This website is intended for an international audience, excluding the UK, United States, Canada and France. This website has been developed by Ipsen in collaboration with those living with NETs and the healthcare professionals who care for them. Ipsen would like to thank everyone for their valuable insights and stories. All names used on this website are not necessarily real names. Visit for more information about us. Website design and development by Kanga Health Ltd. ALL-ALL-002300/November 2020